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Abstract
The effect of trihydroxy (sodium cholate and sodium glycocholate) and dihydroxy (sodium deoxycholate and
sodium glycodeoxycholate) bile salt micelles on the spectrophotometric properties and on the solubility of nitrazepam
in aqueous solution, at 25.0°C and at ionic strength 0.1 M in sodium chloride, has been assessed. From the results
obtained it was possible to calculate the partition coefficients (Kp) of nitrazepam between aqueous and micellar
phases. The partition coefficients of nitrazepam have also been determined in mixed micelles of cholate or
deoxycholate with lecithin (egg yolk phosphatidylcholine), which were used as a model of the gastrointestinal tract.
Drug partition was found to depend on the bile acid (number of hydroxyl groups and conjugation with glycine), and
our data indicate further that addition of lecithin to bile salt micelles decreases the values of the partition coefficients
in the mixed micelles at physiological pH. © 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bile salts, having a large, rigid, and planar
hydrophobic moiety of a steroid nucleus with two
or three hydroxyl groups, are a special group of
biosurfactants, whose properties differ consider-
ably from ordinary aliphatic surfactant molecules
[1,2], namely bile salts have lower aggregation
number and rigidity, and smaller surface charge
density than conventional aliphatic surfactants [3].
Micellar solubilization, the enhanced aqueous
solubility of otherwise poorly soluble organic sub-
stances brought about by the presence of surfac-
tant micelles, which is caused by their
incorporation into micelles, plays a very impor-
tant role in biological processes, such as adsorp-
tion and transfer of materials in living tissues
[4,5]. Bile salts are considered to enhance the
intestinal absorption of drugs orally administrated
by interacting with the drug, eventually by drug
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incorporation after micelle formation, and also by
altering the permeability of the biological mem-
brane [6–10].
Bile salts in the human body are often associ-
ated with long-chain fatty acid esters of phos-
phatidylcholine in mixed micelles, and the
physicochemical behavior of these mixed micelles
has been extensively studied due to the potential
applications in the design of drug-delivery systems
for poorly soluble drugs and in oral formulations
[11]. These mixtures have been used as bile models
and the principles governing their self-assembly
may help to understand the structure and action
of native bile in emulsifying lipophilic compounds
in the bile duct, gall bladder and intestine. In the
recent ‘locally cylindrical’ model of mixed micelles
[12], the acyl chains of phosphatidylcholine are
oriented toward the center of the wormlike mixed
micelle with their zwitterionic head groups facing
outward. On the other hand, bile salt molecules
both ‘cap’ the hydrophobic ends of the mixed
micelle and are dispersed randomly on the surface
of the micelles with their hydrophobic surfaces
interacting with acyl chains of phosphatidyl-
choline and their hydrophilic surfaces and ionic
side chains oriented toward the aqueous contin-
uum [12]. The charge of the phospholipid is par-
tially compensated by the hydroxylic groups of
the bile salts, and as consequence the net superfi-
cial charge is smaller than in simple bile salt
micelles, a factor that may affect the solubilizing
capacity of the mixed systems [13]. Indeed, these
mixed systems incorporate hydrophobic com-
pounds due to their large size and the fluidity of
their core, but drugs, which interact predomi-
nantly with the micellar electrostatic surface (op-
posite charges), are poorly incorporated in mixed
micelles of bile salts:lecithin [13].
Quantification of the effect of micelles on spec-
troscopic properties and solubility of pharmaceu-
tical drugs allows for the determination of
partition coefficients. These changes reflect mod-
ifications in the microenvironment of the molecule
undergoing solubilization and can provide a de-
tailed picture for partitioning of the drug in mi-
celles [14].
In this work we have quantified the partition
coefficients of nitrazepam (1,3-dihydro-7-nitro-5-
phenyl-1,4-benzodiazepin-2-one), a benzodi-
azepine, in aqueous solutions of bile salt micelles
and assessed the role of added phosphatidyl-
choline in their values. We have determined the
partition coefficients between the aqueous and
micellar pseudo-phases by spectrophotometry and
by solubility measurements, and in the latter case
the data is compared with those obtained in SDS.
The results have shown that drug partition de-
pends on the bile acid (number of hydroxyl
groups and conjugation with glycine). Further-
more, our data indicate that addition of lecithin
to bile salt micelles decreases the values of the
partition coefficients in the mixed micelles at
physiological pH.
2. Experimental
2.1. Reagents and solutions
Nitrazepam, bile salts (sodium cholate, sodium
glycocholate, sodium deoxycholate and sodium
glycodeoxycholate), sodium dodecyl sulphate
(SDS) and egg yolk lecithin (EPC) were from
Sigma and used as received; all other chemicals
were from Merck (pro analysi). All solutions were
prepared with double deionized water (conductiv-
ity less than 0.1 mS cm1). Bile salt solutions were
prepared by rigorous dilution of a stock solution
of known titre, which has been determined by
conductimetric titrimetry with HCl 0.1 M (Merck,
Titrisol). For all solutions studied, the ionic
strength (I) was adjusted to 0.1 M with NaCl.
2.2. pH and spectrophotometric measurements
The automatic system used to measure pH has
been described elsewhere [15]; and system calibra-
tion was performed by the Gran method [16] in
terms of hydrogen ion concentration, using strong
acid:strong base titrimetry. All absorption spectra
were recorded with a Hitachi U-2000 dual-beam
spectrophotometer using quartz cells with 1-cm
path length that were thermostated at 25.0°C.
In the solubility studies, calibration curves (A
vs. concentration) were constructed for the neu-
tral (308 nm) and for the deprotonated (364 nm)
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forms of nitrazepam for each concentration of
bile salts used. The Beer–Lambert law was
obeyed in the concentration range used (1.0
105–2.5105 M for the neutral form, and
2.6105–5.0105 M for the deprotonated
form), both in aqueous and in micellar solutions.
The reported data are the average of four
different measurements, in which the blank
was a solution with the same bile salt concentra-
tion and at the same ionic strength, but without
the drug.
2.3. Solubility studies
The solubility of the neutral and deprotonated
forms of nitrazepam was measured in water, and
in aqueous SDS and in bile salt solutions, below
and above the cmc. The following concentrations
were used: for SDS, seven solutions in the range
1.0103–2.0102 M; for sodium deoxy-
cholate and sodium glycodeoxycholate, nine solu-
tions in the range 1.0103–6.5103 M; for
sodium glycocholate, eight solution in the range
6.0103–4.5102 M; for sodium cholate,
nine solution in the range 4.0103–3.0102
M. The cmc values for the bile salts in aqueous
solutions with I0.1 M (NaCl) are: 6.0103
M (sodium cholate); 1.2102 M (sodium glyco-
cholate); 2.5103 M (sodium deoxycholate);
and 2.2103 M (sodium glycodeoxycholate)
[17].
For each solution, the benzodiazepine was dis-
persed in 20 ml of each solvent and the pH
adjusted to 7.0 or to 11.5, by addition of concen-
trated HCl or NaOH. The saturated solutions
were incubated for 48 h at 25.090.1°C in a
thermostated bath, and then filtrated through
filter paper (Lida, 0.45 mm). The concentration of
nitrazepam was determined spectrophotometri-
cally at the wavelength of maximum absorbance,
after the appropriate dilution with a solution with
the same composition, but in which the drug was
absent. In each case, the corresponding solvent
system diluted in the same way as the measured
filtrate was used as to correct any absorbance of
the surfactant and as a solvent to prepare working
standard solutions of each drug studied for the
construction of a calibration curve.
2.4. Preparation of mixed micelle solutions
Mixed micelles of lecithin (concentrations of
500106 and 750106 M) and bile salts
were prepared by dissolving a known amount of
lecithin in chloroform:methanol (10:1, v:v), to
which was added sodium cholate or sodium de-
oxycholate by rigorous dilution of a concentrated
methanolic solution. The mixture was dried under
vacuum in a rotative evaporator, and the resulting
film was dried under a stream of nitrogen in the
dark for at least 1 h, and was then suspended in
an aqueous solution (I0.1 M NaCl), using a
vortex. For bile salt concentrations below the
cmc, the product was a suspension of lecithin
vesicles, whereas for concentrations higher than
the cmc, clear solutions of mixed micelles were
obtained. In the resulting solutions:suspensions,
the bile salts were assayed by conductimetry, as
described above, and the total concentration of
lecithin was determined by an enzymatic method,
using a kit obtained from Biome´rieux (Lyon,
France). The cmc values of the mixed bile salt:
lecithin micelle in aqueous solutions with I0.1
M are: 9.0104 M, for cholate and 750106
M lecithin; 2.0103 M for cholate and 500
106 M lecithin; 8.0104 M, for deoxycholate
and 750106 M lecithin; and 1.2103 M for
deoxycholate and 500106 M lecithin [17].
2.5. Spectrophotometric determination of partition
coefficients
Aqueous solutions of nitrazepam were added to
solutions of the desired micelles (either simple or
mixed), and the resulting solutions were then in-
cubated in the dark and at 25°C for 12 h. The
partition coefficients of nitrazepam were calcu-
lated at pH 11.5 and 7.0.
In the determinations of partition coefficients in
simple micelles, the concentrations of bile acid
salts were: cholate between 1.0104 and 4.0
102 M; glycocholate between 8.0103 and
5.0102 M; deoxycholate between 5.0104
and 6.0103 M; glycodeoxycholate between
5.0104 and 6.5103 M. For mixed micelles
the following concentrations of surfactants were
used: (a) 750106 M lecithin, cholate from
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5.0104 to 3.0102 M, and deoxycholate
from 1.0104 to 7.0103 M; (b) 500106
M lecithin, cholate from 4.0104 to 3.0102
M, and deoxycholate from 5.0104 to 7.0
103 M. Total concentration of nitrazepam in the
final solutions was always smaller than 5105
M, and the blank was the same solvent system
with the same concentration of surfactants, but
without the drug.
3. Results
Nitrazepam has two acid equilibria in solution
H2B X HHB X HB– (1)
but in the pH range used (7 and 11.5) only the
second equilibrium is important, as the pKa values
are pKa12.9890.01 and pKa210.5590.03
[15], and thus only two forms of the drug exist in
significant amounts in solution: the neutral (HB)
and the deprotonated (B–).
3.1. Partition coefficients of nitrazepam in bile
salt micelles determined by distribution methods.
The solubility of both forms of nitrazepam in
bile salt solutions is practically constant till the
cmc, after which increases with bile salt concen-
tration, and finally levels off at high concentra-
tions. In Fig. 1 plots of solubility of nitrazepam
vs. surfactant concentrations are presented for
sodium deoxycholate, sodium glycodeoxycholate
and SDS. This increase in solubility was found to
be more pronounced for the neutral form of
nitrazepam and to depend on bile salt conjuga-
tion. The drug is always more soluble in glyco-
cholate or in glycodeoxycholate, thus implying
that glycine conjugation increases drug solubility,
as has been found for other hydrophobic
drugs [17]. The solubility of the negatively
charged forms of nitrazepam does not change
with the content of SDS and only the neutral
forms of this benzodiazepine are increasing solu-
ble in SDS.
The binding constant of any substance to mi-
celles can be related with solubility through the
expression KBm (SmSw):SwCD [18–21], where
CD is the micellized bile salt concentration (equal
to the difference between the total surfactant con-
centration and the critical micellar concentration)
[14,22]. Application of this equation to a neutral
acid molecule (HB) and its conjugate form (B)
yields the following expressions:
Sm
Sw
1KHBm CD (2)
Sm
Sw
1KB
m CD (3)
Fig. 1. Nitrazepam solubility in aqueous solutions of sodium
deoxycholate (circles), sodium glycodeoxycholate (squares)
and SDS (triangles) at pH 7.0 (filled symbols) and 11.5 (open
symbols).
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Fig. 2. Graphical representation of (SmSw)1 vs. CD of
sodium glycodeoxycholate for nitrazepam at pH 7.0 (circles;
y3358x0.4886; R20.992) and 11.5 (squares; y
1447x0.3686; R20.993).
the surfactant. Values of Vf for the bile salts
studied are: 0.75 cm3 g1 (sodium cholate); 0.75
cm3 g1 (sodium glycocholate); 0.77 cm3 g1
(sodium deoxycholate); and 0.77 cm3 g1 (sodium
glycodeoxycholate) [25,26]. In Table 1 are pre-
sented the values of the partitions coefficients
calculated from the corresponding binding con-
stant using this approach.
3.2. Spectrophotometric determination of partition
coefficients of nitrazepam in bile salt micelles
The experimental spectra on nitrazepam in mi-
cellar media are the sum of those of free and
micelle bound forms of the drug. The observed
absorbance, Ai, is thus the sum of the absorbance
in aqueous, Aw, and in micellar solutions, Am, and
its value can be related to free and micelle bound
concentrations by Aiow [B]wom [B]m. By let-
ting oomow and bo [B]T, and replacing
these values in Eq. (4), the following equation can
be obtained [24]
AiAw
bKpCD
1KpCD
(7)
which relates experimental absorbance with parti-
tion coefficients. The values of the partition coeffi-
These latter equations were found to be valid only
for bile salt concentrations for which the solubil-
ity changes appreciable, but not for high concen-
trations of surfactant where drug solubility
remains constant. Plots of (SmSw)1 vs. CD
are linear and from the slopes it is possible to
calculate the corresponding binding constants.
Such a plot for nitrazepam in sodium glycodeoxy-
cholate is depicted in Fig. 2.
Typically, drug partition is not quantified by
binding constant, but by partition coefficients.
These are defined by [23,24]:
Kp
([B]m:[B]T):CD
([B]w:[B]T):[w]
(4)
where [w] is the molar concentration of water and
[B]T the total concentration of nitrazepam (B);
[B]m:[B]T is the mole fraction in the micelle (m);
[B]w:[B]T is the mole fraction in water (w).
The values of the binding constants can be
converted into partition coefficients (Kp) through
the following equations [22]:
KHBm  (kp, HB1)Vf (5)
KB
m  (kp, B1)Vf (6)
where Vf is the partial specific molar volume of
Table 1
Partition coefficients (M1) of nitrazepam in bile salt micelles
of sodium cholate (NaC), sodium glycocholate (NaGC),
sodium deoxycholate (NaDC) and sodium glycodeoxycholate
(NaGDC) obtained by spectrophotometry and by solubility
measurements at 25°C, I0.10 M; pH 7.0 and 11.5
SolubilitySpectrophotometryBile salt
pH 11.5c pH 7.0dpH 7.0bpH 11.5a
2306940NaC 599917 2284920 625920
712916 2430920 739920 2440930NaGC
NaDC 30259371035938 1113950 3125960
1310940 3280942 1448950 3358940NaGDC
a The results are the average of at least two independent
experiments each with values obtained at 364, 400 and 350 nm.
b The results are the average of at least two independent
experiments each with values obtained at 308 and 258 nm.
c The reported values are the average of four different
measurements at 364 nm.
d The reported values are the average of four different
measurements at 308 nm.
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cients can thus be obtained by fitting Eq. (7) to
the experimental absorbance data. This equation
can be linearized to yield [17,24]
(AwAi)1 (AwAm)1

1
(AwAm)Kp
(CD)1 (8)
which can be used test visually the applicability of
the model and to provide approximate values of
Kp to be used in the non-linear minimization.
3.3. Bile salt micelles. Partition coefficients of
nitrazepam
Absorbance spectra of nitrazepam in bile salt
solutions below their cmc are identical to those in
the absence of bile salt. However, above the cmc,
band intensity decreases as the concentration of
the bile salt increases, but without changes in
band maxima. This behavior was observed for
both forms of the drug and for all bile salts
studied.
The partition coefficients of nitrazepam be-
tween the aqueous and the micellar pseudo-phases
were calculated by fitting Eq. (7) to the experi-
mental data with correlation coefficients higher
than 0.99, and the calculated values are included
in Table 1. Furthermore, from the values of b it is
possible to calculate the values of om for ni-
trazepam, and the following values have been
obtained (values at pH 7.0 first, and then at pH
11.5): in sodium cholate, 3390990 and 58209
80; in sodium glycocholate, 3580980 and 60509
70; in sodium deoxycholate 37509120 and
63709110; in sodium glycodeoxycholate, 37809
110 and 6600990 (the values are the average of
at least three independent measurements). In Fig.
3 the experimental values of absorbance intensity
of nitrazepam are plotted as a function of CD, for
sodium deoxycholate solutions; and superimposed
is the curve obtained from Eq. (7) that best de-
scribes the experimental data.
3.4. Mixed bile salt:lecithin micelles. Partition
coefficients of nitrazepam
The partition coefficients were obtained only
Fig. 3. Absorbance intensity (A) of nitrazepam, obtained at
pH 7.0 (at 308 nm, circles) and 11.5 (at 364 nm, squares) as a
function of CD for sodium deoxycholate solutions; the line
represents the best fit of Eq. (7) (see text), obtained by
non-linear regression.
for mixed micelles of sodium cholate and sodium
deoxycholate with lecithin, and for two concentra-
tions of phospholipid, either 500106 or 750
106 M. The values of Kp were calculated from
spectrophotometric data by using the approach
outlined for bile salt micelles (see above), and in
Table 2 are presented the values for nitrazepam in
the mixed micelles.
Table 2
Partitions coefficients (M1) of nitrazepam in mixed bile
salt:lecithin micelles obtained by spectrophotometry at 25°C,
I0.10 M and at two lecithin concentrations
pH 11.5bBile salta pH 7.0c
576937 1340929NaC:lecithin 500 mM
1096932NaC:lecithin 750 mM 1052931
25589921417918NaDC:lecithin 500 mM
2012990 16599120NaDC:lecithin 750 mM
a NaC, sodium cholate; NaDC, sodium deoxycholate.
b The results are the average of at least two independent
experiments each with values obtained at 364, 400 and 350 nm.
c The results are the average of at least two independent
experiments each with values obtained at 308 and 258 nm.
B. de Castro et al. : J. Pharm. Biomed. Anal. 24 (2001) 595–602 601
4. Discussion
4.1. Bile salt micelles
Analysis of data in Table 1 shows that the
partition constants determined by two experimen-
tal methods and using different theoretical models
are similar, which provides support for the models
used.
However, some comments must be made re-
garding nitrazepam solubility in bile salt micelles.
At pH 7.0 the drug exists mainly in the neutral
form, which is one order of magnitude less soluble
than the negatively charged form, predominant at
pH 11.5. Upon addition of bile salts the solubility
of both forms increase, but with that of the
neutral form to a much larger extent: in cholate
micelles the increase in solubility is 37% for the
neutral form and 6% for the deprotonated form.
The corresponding values for the other bile salts
are: 58 and 15%, for glycocholate; 13 and 5%, for
deoxycholate; and 15 and 5% for glycodeoxy-
cholate. The increase in solubility of the neutral
form correlates with the known high hydrophobic
properties of neutral benzodiazepines [13,17,19],
for which strong hydrophobic interactions with
the lipophilic steroid nucleus of bile salts are to be
expected.
It is of interest to compare the solubility (parti-
tion coefficients) of nitrazepam in simple bile salt
and in SDS micelles. In the latter, the head groups
are sulphate ions, whereas in bile salt micelles the
head groups are negatively charged carboxylate
and neutral hydroxyl groups, which impart a
smaller net surface charge density to these natu-
rally occurring micelles. Thus, only the neutral
forms of nitrazepam and of other benzodiazepines
are increasing soluble in SDS, due to their hydro-
phobic character [19]. The solubility of the nega-
tively charged form does not increase with the
content of SDS, as the electrostatic repulsion be-
tween SDS sulphate groups and the negatively
charged groups of nitrazepam overcome hydro-
phobic interactions between their non-polar frag-
ments. A possible explanation for the solubility
increase of negatively charged nitrazepam with
bile salt concentration, may be provided by noting
that the negative surface charge density of bile
salt micelles is much less than in SDS micelles,
which can allow for some hydrophobic interac-
tions between drug and micelle. The existence of
hydroxyl groups in the surface of bile salt micelles
makes electrostatic repulsions between the nega-
tively charged groups of the drug and of the
micelles less severe, and thus the hydrophobic
forces are not completely annulated.
It is also clear that both forms of nitrazepam
interact with any of bile salts studied, although to
a much larger extent with the dihydroxy bile salts.
Furthermore, conjugation of the bile salts with
glycine increases the solubility of nitrazepam and
consequently the values of Kp. These observations
are in agreement with the behavior of other phar-
maceutical compounds in bile salt solutions previ-
ously investigated [17].
4.2. Mixed bile salt:lecithin micelles
Mixed micelles, which result after addition of
lecithin to bile salt micelles, are larger and have a
more fluid core then simple bile salt micelles, but
their net surface charge density is smaller [11,13].
Analysis of data in Table 2 shows that the
neutral and deprotonated forms of the drug have
different behaviors when lecithin content is in-
creased. The partition coefficients of the neutral
form decrease with increasing lecithin content,
and these reductions are :60% for mixed mi-
celles with sodium cholate, and :50% with
sodium deoxycholate. This behavior is similar to
that observed for other neutral drugs that are
slightly soluble in water, for which it is to be
expected that they are not extensively incorpo-
rated in the hydrophobic core of the micelles
[19,20]. On the other hand, this result must be
contrasted with that for highly hydrophobic com-
pounds, e.g. cholesterol, for which the partition
coefficients increase significantly with lecithin con-
tent [21,27]
More striking is the increase in the partition
coefficients of the deprotonated form of ni-
trazepam with increasing lecithin content. Re-
calling the explanation advanced for the increase
in solubility of the negatively charged form of
nitrazepam with bile salt concentration, we pro-
pose that the increase observed with increasing
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lecithin content, must also be ascribed to the
decrease in net surface charge of the mixed mi-
celles, notwithstanding the possibility of the ‘polar
heads’ of the negatively charged form of ni-
trazepam interacting the positive charges in the
lecithin.
As a final commentary we note that mixed
micelles incorporate larger amounts of hydropho-
bic compounds due to their large size and the
fluidity of their core [13], but that incorporation
of neutral amphiphilic drugs is less extensive in
bile acids:lecithin micelles. These results can be
relevant to benzodiazepine bioavailability by de-
creasing their absorption from the gastrointestinal
tract.
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